Return to Today's science sparks archives
Click the tweet icon above each article title to share it on Twitter.
|
Fig 1b. A positive RET FISH break-apart test. Split green and red signals indicate the presence of a RET fusion.
|
|
|
Fig 1a. Transverse in-phase (a TE, 4.2 ms) chemical shift 1.5-T MR images in a 56-year-old man with a clear cell carcinoma.
|
|
|
Fig 1a. Expression of Hoxd10 during bud outgrowth (bottom) with a schematic illustration of the early (green) and late (purple) phases of expression (top).
|
|
|
Fig 1. Percentage of Patients Meeting Recommended Daily Intake For Each Identified Food Group.
|
|
|
Fig. 1. Tumor-to-organ ratios in terms of FDG uptake in mice with PC3 xenografts.
|
|
|
Fig 2. Elastography of irreversible electroporation (IRE) ablation.
|
|
|
Fig 1. Patterns of recurrence and sites of metastasis in primary leiomyosarcoma. (b). Sites of metastasis in all patients; site of first DR (i) and all DR (ii).
|
|
|
Fig 4. p-Y393-AGO2 enhances cell survival and invasiveness under hypoxia and correlates with poorer overall survival in breast cancer patients. (d) Representative images of immunohistochemical staining of p-Y393-AGO2 in human breast tumour and its adjacent normal tissue.
|
|
|
Fig 1. Kaplan–Meier curves illustrating cumulative locoregional (LR) recurrence free probability in pathologically downstaged N0 versus N1 disease.
|
 |
|
Fig 2. Kaplan–Meier analysis of (A) PFS (data cut-off of September 2010) and (B) overall survival (data cut-off of February 2012).
|
|
|
Figure 1. Molecular hybridization of lead compounds 1 and 2 to create a new template.
|
|
|
Figure 1. Monthly and cumulative accrual to Cancer and Leukemia Group B 100104.
|
|
|
Figure 2. Ventral folding morphogenesis encompasses multiple concurrent tissue rearrangements
|
|
|
Fig 1. The estimated numbers of cancer survivors in (Top) the United States in 2010 and (Bottom) the European Union in 2008 are compared with the numbers of new cancer diagnoses and deaths for the same years.
|
|
|
Fig 1. Localization and regulation of lipid-modified proteins.Conceptual diagram of representative proteins modified with various lipophilic groups.
|
|
|
Fig 4. A) Coronal MIP of 18F-FDG PET images of a 44 year old woman diagnosed with recurrent cervical cancer initially treated with definitive chemoradiotherapy. The patient was without evidence of disease on her last follow-up. B, C) Transverse CT and fused PET/CT images, with the recurrence (arrow), D, E) Sagittal CT and fused PET/CT images illustrating the recurrence (arrow).
|
|
|
Fig 1. A 58-year-old woman with stage IV breast cancer presented with an enlarging left parasternal chest wall mass.
|
|
|
Fig 1. Flow Diagram of Studies. Two patients who were alive at the end of protocol 1 but who did not participate in protocol 3 were excluded.
|
|
|
Fig 6. Cross-sectional OCT and en face RCM images of the EpiDermFT Skin Model.
|
|
|
Fig 1. Sagittal (A) and axial (B) slices from a 3D-conformal radiation therapy plan.
|
|
|
Fig 1. Recurrence-free survival.
|
|
|
Fig 1a. Experimental strategy to test connectivity between a protein-coding gene and a downstream lincRNA.
|
|
|
Fig 1. CSC robustly maintains oxygen consumption rate constancy in a minimal ETC.
|
|
|
Fig 1. Net benefit plotted against threshold probability for molecular markers of prostate cancer. Gray line: biopsy all men. Thick black line: biopsy no men. Thin black line: biopsy if FT test is positive. Dashed line: biopsy if HK test is positive.
|
|
|
Fig 1. Kaplan-Meier overall survival stratified by disease status.
|
|
|
Fig 1. CONSORT diagram showing patient population from which semen analysis data were derived. HPT XRT, hypothalamic-pituitary irradiation.
|
|
|
Fig 1. Schematic of BrachyView rectal probe. Three side-by-side Medipix detectors are placed inside of the TRUS probe and inferiorly to the prostate gland.
|
|
|
Fig 2. Percentage of endoscopic BPH procedures performed as electrosurgical TURP (CPT 52601, 52612 or 52614) (solid curve) and LP (CPT 52648 or CPT 52649) (dashed line) by year of urologist (re)certification.
|
|
|
Fig. 4. 131I uptake of WRO cells after transfection of 20 nmol of siRNABRAF when grown in three different TSH environments: no TSH (H5), physiological TSH (H6), and media supplemented with ×50 the physiological concentration of TSH (supratherapeutic). 131
|
|
|
Fig 2. miRNAs have oncogene and tumor suppressor activity in natural killer (NK) cells.
|
|
|
Fig 1a. Immunophenotyping and gene-expression of Eμ-ALL01 cells.
|
|
|
Fig 1a. Venn analysis showing the gene expression changes induced by SN12C in the lung stromal compartment. The list shows the genes that were significantly upregulated by SN12C in the lung stroma in comparison with normal mouse lung and lung stroma of mice injected with LM2 cells.
|
|
|
Fig 1. Neoplastic cells with round nuclei, coarse chromatin pattern, and distinct prominent nucleoli were noted in most cells. Occasional interspersed pleomorphic nuclei noted. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
|
|
|
Fig 3. Desmoplastic melanoma, pure type.A. Amelanotic spindle cell melanoma is associated with collagenous stroma and lymphocytic aggregates.
|
|
|
Fig 1. CBCT images of the motion phantom using various acquisition modes.
|
|
|
Fig 4. Example of stereotactic body radiotherapy plan for vertebral body metastasis from Ewing sarcoma.
|
|
|
Fig 3. Spindle cell RMS with TEAD1-NCOA2 fusion. Tumor from a 4-week-old baby boy who was born with a chest wall mass (case RMS4). A: It is composed of short fascicles of spindle cells that have somewhat myofibroblastic appearance, infiltrating adjacent skeletal muscle.
|
|
|
Fig 1. Progression-free survival is illustrated (n = 47). At 2 years, 75% of patients remained progression-free (95% confidence interval, 67%-91%); and, at 3 years, 57% of patients remained progression-free (95% confidence interval, 44%-74%).
|
|
|
Fig 1a. Colonoscopy images from mice before and after 9 cycles of DSS.
|
|
|
Fig 1. Major capsular and vascular invasion with high mitotic activity confirming diagnosis of parathyroid carcinoma.
|
|
|
Fig 3c. Three-dimensional projection of principal component analysis (PCA) of ~8000 probesets expressed in normal hematopoietic precursors (HSCs; common myeloid progenitors (CMPs); megakaryocyte-erythroid progenitors (MEPs); GMPs), LH and LG demonstrate that the leukemia stem cells possess unique gene expression programs.
|
|
|
Fig 1. Mean ± standard deviation and median frequency of benign renal tumors and clear cell renal carcinoma (ccRCC) in studies of patients with renal masses.
|
|
|
Fig 2. Differences in responses of the respondents according to priorities. Black bars, trained surgeon; dark gray bars, trainee; light gray bars, medical student.
|
|
|
Fig 2. Overall survival by Stage (I–III versus IV).
|
|
|
Fig 5. Dermoscopic images of dermatofibroma on thigh of 45-year-old woman.
|
|
|
Fig 1. Estimated survival-time curves for biochemical relapse-free survival (bRFS), distant metastasis-free survival (DMFS), and prostate cancer-specific mortality (PCSM)
|
|
|
Fig 3. Signaling pathways mediated by FGFR3. FGF ligand binding to FGFR3 results in autophosphorylation of the receptor and activation of multiple downstream signaling pathways.
|
|
|
Fig 1.(H): Cutaneous squamous cell carcinoma (histology).
|
|
|
Fig 1. Roles of sumoylated telomere proteins in Saccharomyces cerevisiae.
|
|
|
Fig 3. Plasma concentration:time profiles for three different days at 100 mg/m2. This graph demonstrates a stationary PK with negligible changes upon repeated dosing at weekly intervals.
|
|
|
Fig 3A. Schematic diagrams of promoters for the CYP19A1 gene. The relative tissue specificity for each promoter is listed. The skin/adipose I.4 promoter is highlighted in red.
|
|
|
1(b). RU-SKI 43 inhibition kinetics with purified Hhat. Each point represents mean ± s.d. (n = 2).
|
|
|
Fig. 1. BREAST-Q© conceptual framework.
|
|
|
Fig. 3. Invasive ductal carcinoma NOS (H&E, ×4).
|
|
|
Fig. 1. FACE-Q conceptual framework.
|
|
|
Fig 11. The completed pericardial and diaphragmatic reconstruction. Laterally, the diaphragm is secured by sutures placed around the ribs.
|
|
|
Fig 1. Standard error of measurement (SEM) of Shame and Stigma full scale and subscales, with standardized score estimates and threshold parameters from graded response models (GRMs).
|
|
|
Fig. 2. Frequency of bilateral drainage by lymphoscintigraphy relative to the location of the primary lesion as assessed by hand-drawn schematics, and operative or pathological reports.
|
|
|
Fig 2. Survival based on time from prior chemotherapy.
|
|
|
Fig 1. Axial view demonstrating contrast inside the vaginal cuff.
|
|
|
Fig 1. Thermal images corresponding to power levels of 125, 250, 500, 1000, and 2000 mW and irradiation times of 12 min in a 5-mm slice taken in the center of imaging slab (IP1).
|
|
|
Fig 2a. Model-adjusted probability of nonattrition by risk scores for the dominant multivariate model, among 2,033 postgraduate year (PGY)-1 and PGY-2 residents.
|
|
|
Fig 1. Physicians who performed UD by log year and certification type.
|
|
![Fig 1. Neoplastic cells with round nuclei, coarse chromatin pattern, and distinct prominent nucleoli were noted in most cells. Occasional interspersed pleomorphic nuclei noted. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]](https://library.mskcc.org/sparks/sparksimgs/2063/DiagCytopath_Lin.jpg)
